Stage IV Non-Small Cell Lung Cancer with Driver Alterations Pocket Guide Cover

Stage IV Non-Small Cell Lung Cancer with Driver Alterations Treatment GUIDELINES Pocket Guide

Treatment

Approved By

American Society of Clinical Oncology

Digital Subscription $4.99 Add to Cart
Print $9.95 Add to Cart
Free Sample

The digital version of the Academy Society of Clinical Oncology’s Stage IV Non-Small Cell Lung Cancer with Driver Alterations Treatment GUIDELINES Pocket Guide contains all the same great information found in the pocket guide, and can be accessed on mobile devices and online:

  • ASCO members receive free digital access at www.asco.org/guideline-pocket-cards
  • Price: $4.99
    • Subscribe to additional guideline titles for discounted rates
  • Includes automatic updates during the term of your subscription
  • CPT® and ICD10 codes can be added to certain guidelines for an additional fee
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on the Guideline Central mobile app accessible without an internet connection
    • Access to additional guideline summaries, clinical calculators, and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

The Stage IV Non-Small Cell Lung Cancer with Driver Alterations Pocket Guide supplements the Stage IV NSCLC Stage IV without Driver Alterations Pocket Guide, is based on the latest guidelines of the American Society of Clinical Oncology and was developed with their collaboration. It contains graded recommendations for first- and second-line targeted therapy for EGFR, ALK, ROS1 fusions, BRAF (+/– V600E mutations), MET exon 14 skipping mutations, RET-fusions, and NTRK-fusions in Stage IV NSCLC.

  • Spiral Bound
  • 18 Pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7.25″
  • Key Points
  • Treatment
    • EGFR First- and Second-line
    • ALK First- and Second-line
    • ROS1 First- and Second-line
    • BRAF First- and Second-line
    • MET First- and Second-line
    • RET Rearrangement First- and Second-line
    • NTRK First- and Second-line
  • Table
    • Summary of Recommendations
    • CMS Reimbursement and Oral Drug Prices — Regimens and Prices for Treatment of Stage IV NSCLC with Driver Alterations

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account